Polarean ImagingPLLWF +560.00% Net Current Asset Value is $0.01 as of Jun. 2025, which is 100% below its 10-year median of 4.83. The stock has 4 warning signs investors should review.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Polarean Imaging's net current asset value per share for the quarter that ended in Jun. 2025 was $0.01.
The historical rank and industry rank for Polarean Imaging's Net Current Asset Value or its related term are showing as below:
PLLWF'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.66 Med: 4.83 Max: 14.12
Current: 0.66
During the past 9 years, the highest Price-to-Net-Current-Asset-Value Ratio of Polarean Imaging was 14.12. The lowest was 0.66. And the median was 4.83.
PLLWF's Price-to-Net-Current-Asset-Value is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 5.1
vs PLLWF: 0.66
Polarean Imaging (OTCPK:PLLWF) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Polarean Imaging Net Current Asset Value Related Terms
Polarean Imaging Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Polarean Imaging's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PLLWF vs FOFA, BTCY, LFWD: Net Current Asset Value Comparison
For the Medical Devices subindustry, Polarean Imaging's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.01 mean?
Polarean Imaging (PLLWF) has a Net Current Asset Value of $0.01 as of Jun. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Polarean Imaging and its competitors. This is 100% below median its historical median of 4.83. Over the past decade, Polarean Imaging's Net Current Asset Value has ranged from 0.66 to 14.12.
Is Polarean Imaging's Net Current Asset Value too high?
Polarean Imaging's current Net Current Asset Value of $0.01 is 100% below median its 10-year median of 4.83. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 14.12. The Medical Devices & Instruments industry median Net Current Asset Value is 5.10. Polarean Imaging's value of $0.01 is 99.8% below this industry median.
How does Polarean Imaging's Net Current Asset Value compare to FOFA and BTCY?
Polarean Imaging's Net Current Asset Value of $0.01 can be compared against companies in the Medical Devices & Instruments industry. The industry median Net Current Asset Value is 5.10. Polarean Imaging's value of $0.01 is 99.8% below this benchmark. Historically, Polarean Imaging's own Net Current Asset Value has ranged from 0.66 to 14.12 over the past decade. While the company's 10-year median is 4.83 vs. the industry median of 5.10, Polarean Imaging has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.10, based on 568 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polarean Imaging's current Net Current Asset Value of $0.01 is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Polarean Imaging and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current Net Current Asset Value is $0.01, which is 100% below median its own 10-year median of 4.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (PLLWF) has a current Net Current Asset Value of $0.01. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.5% below its estimated fair value. The current Net Current Asset Value is $0.01, which is 100% below median its 10-year median of 4.83 and 99.8% below the Medical Devices & Instruments industry median of 5.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Polarean Imaging (PLLWF), the current Net Current Asset Value is $0.01 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLLWF has been successfully added to your 